Clinical Trial Update: Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer

View source ↗

Summary

Prospective cohort study evaluating tumor bed boost radiotherapy in HER2-positive breast cancer is currently recruiting at Samsung Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Breast Cancer | Status: RECRUITING